Simple and practical method of Additive Modernization of Preservation Solutions that does not violate the Compliance requirements and Improved the Quality, Efficiency, Safety Transfusion of Preserved RBCs
A. Belousov, E. Malygon, V. Yavorskiy, E. Belousova
{"title":"Simple and practical method of Additive Modernization of Preservation Solutions that does not violate the Compliance requirements and Improved the Quality, Efficiency, Safety Transfusion of Preserved RBCs","authors":"A. Belousov, E. Malygon, V. Yavorskiy, E. Belousova","doi":"10.15226/IJHBD/3/2/00124","DOIUrl":null,"url":null,"abstract":"Red blood cells (RBCs) transfusion is a critical, life-saving treatment for severe anemia caused by disease or chemotherapy, or by blood loss due to trauma or major surgery. For several decades RBCs components have been prepared as concentrates suspended in nutrient additive solution, which preserves and extends the shelf-life of the RBCs component, allowing up to 6–7 weeks of refrigerated storage [1]. Nevertheless, during storage RBCs undergo a complex and progressive accumulation of physicochemical changes, collectively referred to as the RBCs storage lesion [2, 3]. Recent clinical studies have identified RBCs transfusion as an independent risk factor for increased morbidities and mortalities in certain groups of patients, including trauma, cardiac surgery and the critically-ill (reviewed in [4 – 6]). Abstract","PeriodicalId":225199,"journal":{"name":"International Journal of Hematology and Blood Disorders","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hematology and Blood Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15226/IJHBD/3/2/00124","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
Abstract
Red blood cells (RBCs) transfusion is a critical, life-saving treatment for severe anemia caused by disease or chemotherapy, or by blood loss due to trauma or major surgery. For several decades RBCs components have been prepared as concentrates suspended in nutrient additive solution, which preserves and extends the shelf-life of the RBCs component, allowing up to 6–7 weeks of refrigerated storage [1]. Nevertheless, during storage RBCs undergo a complex and progressive accumulation of physicochemical changes, collectively referred to as the RBCs storage lesion [2, 3]. Recent clinical studies have identified RBCs transfusion as an independent risk factor for increased morbidities and mortalities in certain groups of patients, including trauma, cardiac surgery and the critically-ill (reviewed in [4 – 6]). Abstract